Cargando…
F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
E3 ubiquitin ligases play a critical role in cellular mechanisms and cancer progression. F-box protein is the core component of the SKP1-cullin 1-F-box (SCF)-type E3 ubiquitin ligase and directly binds to substrates by various specific domains. According to the specific domains, F-box proteins are f...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086354/ https://www.ncbi.nlm.nih.gov/pubmed/32226545 http://dx.doi.org/10.7150/thno.42735 |
_version_ | 1783509110009888768 |
---|---|
author | Tekcham, Dinesh Singh Chen, Di Liu, Yu Ling, Ting Zhang, Yi Chen, Huan Wang, Wen Otkur, Wuxiyar Qi, Huan Xia, Tian Liu, Xiaolong Piao, Hai-long Liu, Hongxu |
author_facet | Tekcham, Dinesh Singh Chen, Di Liu, Yu Ling, Ting Zhang, Yi Chen, Huan Wang, Wen Otkur, Wuxiyar Qi, Huan Xia, Tian Liu, Xiaolong Piao, Hai-long Liu, Hongxu |
author_sort | Tekcham, Dinesh Singh |
collection | PubMed |
description | E3 ubiquitin ligases play a critical role in cellular mechanisms and cancer progression. F-box protein is the core component of the SKP1-cullin 1-F-box (SCF)-type E3 ubiquitin ligase and directly binds to substrates by various specific domains. According to the specific domains, F-box proteins are further classified into three sub-families: 1) F-box with leucine rich amino acid repeats (FBXL); 2) F-box with WD 40 amino acid repeats (FBXW); 3) F-box only with uncharacterized domains (FBXO). Here, we summarize the substrates of F-box proteins, discuss the important molecular mechanism and emerging role of F-box proteins especially from the perspective of cancer development and progression. These findings will shed new light on malignant tumor progression mechanisms, and suggest the potential role of F-box proteins as cancer biomarkers and therapeutic targets for future cancer treatment. |
format | Online Article Text |
id | pubmed-7086354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-70863542020-03-27 F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects Tekcham, Dinesh Singh Chen, Di Liu, Yu Ling, Ting Zhang, Yi Chen, Huan Wang, Wen Otkur, Wuxiyar Qi, Huan Xia, Tian Liu, Xiaolong Piao, Hai-long Liu, Hongxu Theranostics Review E3 ubiquitin ligases play a critical role in cellular mechanisms and cancer progression. F-box protein is the core component of the SKP1-cullin 1-F-box (SCF)-type E3 ubiquitin ligase and directly binds to substrates by various specific domains. According to the specific domains, F-box proteins are further classified into three sub-families: 1) F-box with leucine rich amino acid repeats (FBXL); 2) F-box with WD 40 amino acid repeats (FBXW); 3) F-box only with uncharacterized domains (FBXO). Here, we summarize the substrates of F-box proteins, discuss the important molecular mechanism and emerging role of F-box proteins especially from the perspective of cancer development and progression. These findings will shed new light on malignant tumor progression mechanisms, and suggest the potential role of F-box proteins as cancer biomarkers and therapeutic targets for future cancer treatment. Ivyspring International Publisher 2020-03-04 /pmc/articles/PMC7086354/ /pubmed/32226545 http://dx.doi.org/10.7150/thno.42735 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Review Tekcham, Dinesh Singh Chen, Di Liu, Yu Ling, Ting Zhang, Yi Chen, Huan Wang, Wen Otkur, Wuxiyar Qi, Huan Xia, Tian Liu, Xiaolong Piao, Hai-long Liu, Hongxu F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects |
title | F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects |
title_full | F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects |
title_fullStr | F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects |
title_full_unstemmed | F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects |
title_short | F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects |
title_sort | f-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086354/ https://www.ncbi.nlm.nih.gov/pubmed/32226545 http://dx.doi.org/10.7150/thno.42735 |
work_keys_str_mv | AT tekchamdineshsingh fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT chendi fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT liuyu fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT lingting fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT zhangyi fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT chenhuan fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT wangwen fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT otkurwuxiyar fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT qihuan fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT xiatian fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT liuxiaolong fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT piaohailong fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects AT liuhongxu fboxproteinsandcanceranupdatefromfunctionalandregulatorymechanismtotherapeuticclinicalprospects |